PDCD1LG2 and neoplasm: Thus, PD-1 and PD-L1 inhibitors/antibodies have been able to restore the T cells function in peripheral tissues by blocking the direct binding of T cell expressing PD-1 with PD-L1 or PD-L2 on tumor cells [10, 11].